M Stahl, J Roehmel, M Eichinger… - Annals of the …, 2024 - atsjournals.org
Rationale: Clinical trials show that lumacaftor/ivacaftor (LUM/IVA) treatment has the potential
to modify early cystic fibrosis (CF) disease progression in children as young as 2 years of …